Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business models in the financial capital. He has been recognised by heading Alzheimer’s disease drug trials for the UK market by venturing a new drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia andYemen. Singh attained his education at The Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and Development.
Shantanu Singh {Taj Pharmaceuticals} Latest News and Updates, Special Reports, Videos
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.